Transcranial Magnetic Stimulator: Clinical Trials

6 trials of Transcranial Magnetic Stimulator, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 withdrawn. 2 Not applicable, 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Withdrawn 1
Phase 12Completed 2
Phase 21Completed 1

Follow Transcranial Magnetic Stimulator: new trials by email Literature Review of Transcranial Magnetic Stimulator trials Research Report on Transcranial Magnetic Stimulator

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
rTMS for Peripartum Depression
Transcranial Magnetic Stimulator - Postpartum Depression, Antepartum Depression
Not applicableWithdrawnUniversity of Calgary2023-05-182023-09-13
D-Cycloserine+iTBS PK Study
D-cycloserine, Transcranial Magnetic Stimulator - Major Depressive Disorder
Phase 1CompletedUniversity of Calgary122022-10-122023-09-11
Treatment of Major Depressive Disorder in the UK Using TMS Therapy
Transcranial Magnetic Stimulator - Major Depressive Disorder
WithdrawnNeuronetics2020-03-012021-10-08
Adjunctive D-Cycloserine in Major Depressive Disorder
D-cycloserine, Transcranial Magnetic Stimulator, Placebo oral capsule - Major Depressive Disorder
Phase 2CompletedUniversity of Calgary502019-12-012022-01-10
Effect of Transmagnetic Stimulation on Conditioned Pain Modulation (CPM)
TMS system MagPro x100, Tonica Elektronik A/S, Denmark - Headache, Migraine
Not applicableCompletedRambam Health Care Campus942011-01-012019-03-27
Accelerated Transcranial Magnetic Stimulation (TMS) for Depression
Transcranial magnetic Stimulator - Depression
Phase 1CompletedUS Department of Veterans Affairs202005-02-012014-09-19

Conditions studied

Depressive Disorder, Major (3)  ·  Depression (1)  ·  Depression, Postpartum (1)  ·  Headache (1)  ·  Migraine Disorders (1)  ·  Parkinson Disease (1)

Sponsors

University of Calgary (3)  ·  Neuronetics (1)  ·  Rambam Health Care Campus (1)  ·  US Department of Veterans Affairs (1)

Countries

Canada (3)  ·  Israel (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Alexander McGirr, MD PhD (3)  ·  David Yarnitsky, professor (1)  ·  Mohamed Abdelghani, MBBCh, MSc, MRCPsych (1)

Results publications

PMID 20734360, PMID 36223114